(Post-pandemic Era)-Global The Vector-Based RNAi Market Segment Research Report 2024

Report ID: 876462 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global The Vector-Based RNAi Market Segment Research Report 2021
1. Research Scope
2. Market Overview
    2.1 Product Introduction, Application, Picture
    2.2 Global The Vector-Based RNAi Market by Value
      2.2.1 Global The Vector-Based RNAi Revenue by Type
      2.2.2 Global The Vector-Based RNAi Market by Value (%)
    2.3 Global The Vector-Based RNAi Market by Production
      2.3.1 Global The Vector-Based RNAi Production by Type
      2.3.2 Global The Vector-Based RNAi Market by Production (%)

3. The Major Driver of The Vector-Based RNAi Industry
    3.1 Historical & Forecast Global The Vector-Based RNAi Demand
    3.2 Largest Application for The Vector-Based RNAi (2017-2027)
    3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Vector-Based RNAi Market
    4.1 Regional Market Size in Terms of Production & Demand (2021)
    4.2 Regional Market Share in Terms of Revenue (2019-2027) 
    4.3 Concentration Ratio (CR5& CR10) of The Vector-Based RNAi Market
    4.4 Mergers & Acquisitions, Expansion Plans

5. US The Vector-Based RNAi Production, Demand (2017-2027)
    5.1 Current and Estimated Production Breakdown by Type
    5.2 Current and Estimated Demand Breakdown by Type
    5.3 Current and Estimated Demand Breakdown by Application
    5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Vector-Based RNAi Production, Demand (2017-2027)
    6.1 Current and Estimated Production Breakdown by Type
    6.2 Current and Estimated Demand Breakdown by Type
    6.3 Current and Estimated Demand Breakdown by Application
    6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Vector-Based RNAi Production, Demand (2017-2027)
    7.1 Current and Estimated Production Breakdown by Type
    7.2 Current and Estimated Demand Breakdown by Type
    7.3 Current and Estimated Demand Breakdown by Application
    7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Vector-Based RNAi Production, Demand (2017-2027)
    8.1 Current and Estimated Production Breakdown by Type
    8.2 Current and Estimated Demand Breakdown by Type
    8.3 Current and Estimated Demand Breakdown by Application
    8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Vector-Based RNAi Production, Demand (2017-2027)
    9.1 Current and Estimated Production Breakdown by Type
    9.2 Current and Estimated Demand Breakdown by Type
    9.3 Current and Estimated Demand Breakdown by Application
    9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Vector-Based RNAi Production, Demand (2017-2027)
    10.1 Current and Estimated Production Breakdown by Type
    10.2 Current and Estimated Demand Breakdown by Type
    10.3 Current and Estimated Demand Breakdown by Application
    10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Vector-Based RNAi Production, Demand (2017-2027)
    11.1 Current and Estimated Production Breakdown by Type
    11.2 Current and Estimated Demand Breakdown by Type
    11.3 Current and Estimated Demand Breakdown by Application
    11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
    11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Vector-Based RNAi Average Price Trend
    12.1 Market Price for Each Type of The Vector-Based RNAi in US (2017-2021)
    12.2 Market Price for Each Type of The Vector-Based RNAi in Europe (2017-2021)
    12.3 Market Price for Each Type of The Vector-Based RNAi in China (2017-2021)
    12.4 Market Price for Each Type of The Vector-Based RNAi in Japan (2017-2021)
    12.5 Market Price for Each Type of The Vector-Based RNAi in India (2017-2021)
    12.6 Market Price for Each Type of The Vector-Based RNAi in Korea (2017-2021)
    12.7 Market Price for Each Type of The Vector-Based RNAi in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
    13.1 The Vector-Based RNAi Industrial Chain Analysis
    13.2 Downstream
    13.3 Impact of COVID-19
    13.4 Technology Trends of The Vector-Based RNAi

14. The Vector-Based RNAi Competitive Landscape
     14.1 Merck & Co.
        14.1.1 Merck & Co. Company Profiles
        14.1.2 Merck & Co. Product Introduction
        14.1.3 Merck & Co. The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.1.4 Strategic initiatives
     14.2 Dicerna Pharmaceuticals
        14.2.1 Dicerna Pharmaceuticals Company Profiles
        14.2.2 Dicerna Pharmaceuticals Product Introduction
        14.2.3 Dicerna Pharmaceuticals The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.2.4 Strategic initiatives
     14.3 Thermo Fisher Scientific
        14.3.1 Thermo Fisher Scientific Company Profiles
        14.3.2 Thermo Fisher Scientific Product Introduction
        14.3.3 Thermo Fisher Scientific The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.3.4 Strategic initiatives
     14.4 Phio Pharmaceutical
        14.4.1 Phio Pharmaceutical Company Profiles
        14.4.2 Phio Pharmaceutical Product Introduction
        14.4.3 Phio Pharmaceutical The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.4.4 Strategic initiatives
     14.5 Ionis Pharmaceutical
        14.5.1 Ionis Pharmaceutical Company Profiles
        14.5.2 Ionis Pharmaceutical Product Introduction
        14.5.3 Ionis Pharmaceutical The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.5.4 Strategic initiatives
     14.6 Quark Pharmaceuticals
        14.6.1 Quark Pharmaceuticals Company Profiles
        14.6.2 Quark Pharmaceuticals Product Introduction
        14.6.3 Quark Pharmaceuticals The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.6.4 Strategic initiatives
     14.7 Arcturus Therapeutics
        14.7.1 Arcturus Therapeutics Company Profiles
        14.7.2 Arcturus Therapeutics Product Introduction
        14.7.3 Arcturus Therapeutics The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.7.4 Strategic initiatives
     14.8 Qiagen NV
        14.8.1 Qiagen NV Company Profiles
        14.8.2 Qiagen NV Product Introduction
        14.8.3 Qiagen NV The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.8.4 Strategic initiatives
     14.9 Silence Therapeutics
        14.9.1 Silence Therapeutics Company Profiles
        14.9.2 Silence Therapeutics Product Introduction
        14.9.3 Silence Therapeutics The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.9.4 Strategic initiatives
     14.10 Arrowhead Pharmaceuticals
        14.10.1 Arrowhead Pharmaceuticals Company Profiles
        14.10.2 Arrowhead Pharmaceuticals Product Introduction
        14.10.3 Arrowhead Pharmaceuticals The Vector-Based RNAi Sales, Revenue (2017-2021)
        14.10.4 Strategic initiatives
     14.11 Alnylam Pharmaceuticals
15. Conclusion


List of Tables and Figures

    Figure 1. Total Demand by Application of The Vector-Based RNAi Industry (Volume)
    Figure 2. The Vector-Based RNAi Production & Demand by Regions in 2021
    Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
    Figure 4. The Top 10 and 5 Players Market Share by The Vector-Based RNAi Revenue in 2021
    Figure 5. US The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 6. Production Breakdown by Type (%)
    Figure 7. Demand Breakdown by Type (%)
    Figure 8. Demand Breakdown by Application (%)
    Figure 9. Revenue Breakdown by Type (%)
    Figure 10. Revenue Breakdown by Application (%)
    Figure 11. Europe The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 12. Production Breakdown by Type (%)
    Figure 13. Demand Breakdown by Type (%)
    Figure 14. Demand Breakdown by Application (%)
    Figure 15. Revenue Breakdown by Type (%)
    Figure 16. Revenue Breakdown by Application (%)
    Figure 17. China The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 18. Production Breakdown by Type (%)
    Figure 19. Demand Breakdown by Type (%)
    Figure 20. Demand Breakdown by Application (%)
    Figure 21. Current and Estimated Revenue Breakdown by Type
    Figure 22. Revenue Breakdown by Type (%)
    Figure 23. Revenue Breakdown by Application (%)
    Figure 24. Japan The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 25. Production Breakdown by Type (%)
    Figure 26. Demand Breakdown by Type (%)
    Figure 27. Demand Breakdown by Application (%)
    Figure 28. Revenue Breakdown by Type (%)
    Figure 29. Revenue Breakdown by Application (%)
    Figure 30. India The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 31. Production Breakdown by Type (%)
    Figure 32. Demand Breakdown by Type (%)
    Figure 33. Demand Breakdown by Application (%)
    Figure 34. Revenue Breakdown by Type (%)
    Figure 35. Revenue Breakdown by Application (%)
    Figure 36. Korea The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 37. Production Breakdown by Type (%)
    Figure 38. Demand Breakdown by Type (%)
    Figure 39. Demand Breakdown by Application (%)
    Figure 40. Revenue Breakdown by Type (%)
    Figure 41. Revenue Breakdown by Application (%)
    Figure 42. Southeast Asia The Vector-Based RNAi Production, Demand (2017-2027)
    Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
    Figure 44. Production Breakdown by Type (%)
    Figure 45. Demand Breakdown by Type (%)
    Figure 46. Revenue Breakdown by Type (%)
    Figure 47. Revenue Breakdown by Application (%)
    Figure 48. Industrial Chain
    Table 1. Top Manufacturers and Market Segmentation
    Table 2. Product Introduction, Application, Picture
    Table 3. The Vector-Based RNAi Revenue, by Type (Million USD) (2017-2027)
    Table 4. The Vector-Based RNAi Production, by Type (K Unit) (2017-2027)
    Table 5. The Vector-Based RNAi Demand (K Unit) by Application (2017-2027)
    Table 6. The Vector-Based RNAi Demand (Million USD) by Application (2017-2027)
    Table 7. The Major Downstream Company in China
    Table 8. Regional Market Share in Terms of Production & Demand (2021)
    Table 9. Regional Market Share in Terms of Revenue (2021&2027)
    Table 10. Ranking of Global Top The Vector-Based RNAi Companies by Revenue, Concentration Ratio in 2021
    Table 11. Mergers & Acquisitions, Expansion Plans
    Table 12. US The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 16. Current and Estimated Revenue Breakdown by Type
    Table 17. Current and Estimated Revenue Breakdown by Application
    Table 18. Europe The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 22. Current and Estimated Revenue Breakdown by Type
    Table 23. Current and Estimated Revenue Breakdown by Application
    Table 24. China The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 25. Table Current and Estimated Production Breakdown by Type
    Table 26. Current and Estimated Demand Breakdown by Type
    Table 27. Current and Estimated Demand Breakdown by Application
    Table 28. Current and Estimated Revenue Breakdown by Application
    Table 29. Japan The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 33. Current and Estimated Revenue Breakdown by Type
    Table 34. Current and Estimated Revenue Breakdown by Application
    Table 35. India The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 39. Current and Estimated Revenue Breakdown by Type
    Table 40. Current and Estimated Revenue Breakdown by Application
    Table 41. Korea The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
    Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 45. Current and Estimated Revenue Breakdown by Type
    Table 46. Current and Estimated Revenue Breakdown by Application
    Table 47. Southeast Asia The Vector-Based RNAi Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
    Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
    Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
    Table 50. Current and Estimated Revenue Breakdown by Type
    Table 51. Current and Estimated Revenue Breakdown by Application
    Table 52. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in US (2017-2021)
    Table 53. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in Europe (2017-2021)
    Table 54. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in China (2017-2021)
    Table 55. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in Japan (2017-2021)
    Table 56. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in India (2017-2021)
    Table 57. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in Korea (2017-2021)
    Table 58. Market Price (USD/Unit) for Each Type of The Vector-Based RNAi in Southeast Asia (2017-2021)
    Table 59. Key Downstream Customer in Each Application Field
    Table 60. Merck & Co. Profiles
    Table 61. Merck & Co. The Vector-Based RNAi Product Introduction
    Table 62. Merck & Co. The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 63. Merck & Co. Strategic initiatives
    Table 64. Dicerna Pharmaceuticals Profiles
    Table 65. Dicerna Pharmaceuticals The Vector-Based RNAi Product Introduction
    Table 66. Dicerna Pharmaceuticals The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 67. Dicerna Pharmaceuticals Strategic initiatives
    Table 68. Thermo Fisher Scientific Profiles
    Table 69. Thermo Fisher Scientific The Vector-Based RNAi Product Introduction
    Table 70. Thermo Fisher Scientific The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 71. Thermo Fisher Scientific Strategic initiatives
    Table 72. Phio Pharmaceutical Profiles
    Table 73. Phio Pharmaceutical The Vector-Based RNAi Product Introduction
    Table 74. Phio Pharmaceutical The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 75. Phio Pharmaceutical Strategic initiatives
    Table 76. Ionis Pharmaceutical Profiles
    Table 77. Ionis Pharmaceutical The Vector-Based RNAi Product Introduction
    Table 78. Ionis Pharmaceutical The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 79. Ionis Pharmaceutical Strategic initiatives
    Table 80. Quark Pharmaceuticals Profiles
    Table 81. Quark Pharmaceuticals The Vector-Based RNAi Product Introduction
    Table 82. Quark Pharmaceuticals The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 83. Quark Pharmaceuticals Strategic initiatives
    Table 84. Arcturus Therapeutics Profiles
    Table 85. Arcturus Therapeutics The Vector-Based RNAi Product Introduction
    Table 86. Arcturus Therapeutics The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 87. Arcturus Therapeutics Strategic initiatives
    Table 88. Qiagen NV Profiles
    Table 89. Qiagen NV The Vector-Based RNAi Product Introduction
    Table 90. Qiagen NV The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 91. Qiagen NV Strategic initiatives
    Table 92. Silence Therapeutics Profiles
    Table 93. Silence Therapeutics The Vector-Based RNAi Product Introduction
    Table 94. Silence Therapeutics The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 95. Silence Therapeutics Strategic initiatives
    Table 97. Arrowhead Pharmaceuticals Profiles
    Table 98. Arrowhead Pharmaceuticals The Vector-Based RNAi Product Introduction
    Table 99. Arrowhead Pharmaceuticals The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
    Table 100. Arrowhead Pharmaceuticals Strategic initiatives
    Table 101. Alnylam Pharmaceuticals Profiles
    Table 102. Alnylam Pharmaceuticals The Vector-Based RNAi Product Introduction
    Table 103. Alnylam Pharmaceuticals The Vector-Based RNAi Sales (Unit), Revenue (Million USD) (2017-2021)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global The Vector-Based RNAi Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global The Vector-Based RNAi Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global The Vector-Based RNAi Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports